Peer Review History
| Original SubmissionNovember 30, 2019 |
|---|
|
PONE-D-19-33190 Types and Clinical Outcomes of Chemical Ingestion in the Emergency Department: South Korea, 2011-2016 PLOS ONE Dear Hee Lee, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ACADEMIC EDITOR: This manuscript is not presented in a standard English, I suggest an English native speaker revision. Statistical analysis was not well performed. The main study aim were not clear. I couldn't understand what’s the definition of intentional vs. unintentional groups. There are many comments from reviewers, and conflict between them. I ask you to produce a very well performed revision in order to publish this paper. Especially check the statistical corrections suggested, and try to reduce the tables, focusing on most important data or transferring them into supplementary materials. We would appreciate receiving your revised manuscript by February 3rd. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Martina Crivellari Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements: 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf and http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. We note that you have reported significance probabilities of 0 in places. Since p=0 is not strictly possible, please correct this to a more appropriate limit, eg 'p<0.0001'. 3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide.
4. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The retrospective study reported the major types of chemical poisoning agents in patients who visited ED in South Korea from 2011 to 2016 and accessed the associations between hospital admission/mortality and potential risk factors including intentions of chemical ingestion, patients’ demographics characteristics, time from injury to ED visits, ED LOS, date, time, places of injury occurrence, and so on. My review/comments are from statistical perspective. Study design: Lines 74 – 75: the authors mentioned “all patients were classified into either intentional group or unintentional group.” What’s the definition of intentional vs. unintentional groups? Did patients in intentional group had psychiatric problems? Were those patients susceptible to suicide? The sample of intentional group maybe bias by only including patients who presented at ED. The main study aim were not clearly mentioned. In the materials and methods section, it looks like the authors want to access the association between admitted/discharged and intentions. But, in the results section the authors reported results of parallel analyses on intentional group and unintentional group separately. I recommend the authors setup the primary aims and the corresponding hypotheses before analyzing the data. Statistical Analysis: The author didn’t clearly illustrate covariates used in multiple logistic regression. Did the authors perform any variable selection algorithms? Period from time of injury to ED presentation may have crucial clinical meaning with respect to the primary endpoint (admitted/discharged). The measurement accuracy for intentional group maybe bias because of the potential bias in sampling. In table 4, the author listed ingested chemicals with significant p-values in model. Did the author include single covariate (e.g. chemical agents) with all types of chemicals as different categories? If so, which chemical was defined as the reference level? Or did the author include all types of chemicals as dummy binary covariates? Is it possible that one patient ingested more than one chemicals? In table 4, the authors reported “sulfuric acid” was statistically significant in the multivariable logistic regression and had a very large odds ratio and a huge upper limit (26.132 [3.105, 219.890]). It is confusing me that, in table 2, the admission rates of ingested “sulfuric acid” and “hydrofluoric acid” were 5.7% (n = 2) and 4.5% (n = 3) respectively. But “sulfuric acid” has such a huge odds ratio (OR=26.132) and “hydrofluoric acid” has odds ratio (OR=0.281) less than 1. In addition, among 1673 unintentional ingestion cases only 35 (2.09%) ingested “sulfuric acid”. A quasi complete separation may occur and vague/suspected findings can be drawn. Same issues in intentional group (both discharged vs. admitted and survival vs. mortality) as unintentional group. I recommend authors pay more attention to interpret results of multivariable logistic regressions and move characteristics comparisons from result section to the discussion or supplementary section. For categorical characteristics with more than two categories, it is suspected and tedious to report p-values of Chi-square tests of each category without multiple adjustment. I recommend to perform one single Chi-square test for categorical characteristics and report a single p-value. Additional comments: Line 100 – 101: the authors reported three age groups with p-values < 0.05. Those p-values were separately calculated for each sub-group without showing literature evidence of associations between age groups and intentions of chemical ingestion. I recommend to exclude this sentence or do a multiple comparison adjustment in order to avoid erroneous inferences. Table 1: how to explain different ED LOS? Lines 121 – 122: the sentence is confused. The authors would like to report the top three unintentional chemical ingestions for admitted patients. In order to claim potential associations between admission and type of chemicals, admission rate would be better. Admission rates of ingesting hypochlorites (18.0%) and detergent (15.8%) were less than 20%. However, admission rates of ingesting ethylene glycol was 58.3%. Lines 122 – 124: Why the authors ignored three death cases by ingesting toluene, methanol, and hydrochloric acid? Lines 126 – 127: I recommend to report: the admission rate for male were statistically significantly higher than it for female. Report both admission rates. Lines 127: Report both mean ages if it has clinical meanings. Line 128: collapse insignificant levels and run a single Chi-square test to test association between age groups and admitted/discharged. Table 4: it should be multivariable analysis. Reviewer #2: General Detailed and easy to understand article. However, the main claims of the paper are of interest for South-Korea, mainly. The data presented are less numerous than those already reported in the literature. There are no data about the severity of outcome; the exposure concentrations / exposure doses. There is no real novelty in comparison with previous literature. The English style and language should be checked by an English native speaker. Too many tables. A choice should be made to focus on the most important results. The remaining data could be available as Supplementary Material. Details Line 16: why were only ingestions and not inhalation or other routes of exposure also included? Line 29: “OD” abbreviation: the first time the term is used, write it in full, please. Line 32: “Differences in clinical outcomes by kinds of chemical, and intentionality” : these conclusions have already been reported in the literature Line 33: “… study as a basis for treatment policies etc…”: policies already exist; e.g. Slaughter R’s publication in 2019 about the toxicology of sodium hypochlorite. Lines 47-52: the aim of the article is relevant mainly for South-Korea. Line 61: how many agencies are there in total in South-Korea? Are 20 or 23 agencies representative of the whole country? What is the served population in South-Korea? Line 67: how many cases were excluded due to missing information on intentionality? And to missing on ED outcome? Line 73: “categorized”: according to which classification? Lines 76-77: “insurance type were compared etc…” why? What is the aim? Line 79: “alcohol ingestion before injury…”: any data about the dose? Line 89-90: “a logistic regression analysis was performed to determine the risks of hospital admission and mortality”: separate outcomes or composite outcome? Line 90: “mortality”: in-hospital mortality? Line 91: “p values less than 0.05”: use 95% Confidence Intervals instead of p values (more informative). Line 94: (4741-2712)/4741 = 43%. Please, indicate the reason for exclusion of these 43% of cases. Lines 109-111: “patients in the intentional group had significantly larger proportions of general ward admission, ICU care, and mortality /…/ than the unintentional ingestion group”: is this result really new ? Several articles have already reported that most fatalities after chemical ingestion in adults are intentional (e.g. CDC data from North America). Table 1: “Age distribution in 10 years”, line “81”: add “≥” so as to get “≥ 81” Table 1: “Mode of arrival”: what is the interest of this information? What is the aim? Table 1: “Time interval from injury to ED visit (hrs)”: values between 12 and 13 hrs = very long ! and huge variation; what is the reason? Table 1: “Insurance”: what is the interest of this information? Probably country dependent and difficult to generalize. Table 1: “Place”: place of what? (where the poisoning occurred, I suppose?) Table 4: “Age”: was age entered as a continuous variable? Table 9: 4 rows i.e. “Non-Elderly, glacial acetic acid (-)” up to “Elderly, glacial acetic acid (+)”: consider including an interaction term “age * glacial acetic acid” in the regression model. Line180-182: “The purpose of this study… affected the clinical results”: already said. Lines 187-190: “the 2017 AAPCC annual report… in that order”: this report included all routes of exposures (not only ingestions); so, is it comparable? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Types and clinical outcomes of chemical ingestion in emergency departments in South Korea (2011-2016) PONE-D-19-33190R1 Dear Dr. Hee Lee, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Martina Crivellari Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors quickly responded all my questions/comments, adjust statistical methods, modified the conclusion, and further discussed limitations. A lot of work have been done. I have no further comments. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No |
| Formally Accepted |
|
PONE-D-19-33190R1 Types and clinical outcomes of chemical ingestion in emergency departments in South Korea (2011-2016) Dear Dr. Lee: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Martina Crivellari Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .